- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 20-F Annual report (foreign)
- 2.16 First Supplemental Indenture
- 2.17 Second Supplemental Indenture
- 8 Subsidiaries of the Registrant
- 10.1 Consent of Kesselman & Kesselman
- 10.2 Consent of Ernst & Young LLP
- 12 Certification of Chief Executive Officer Pursuant to Section 302
- 12 Certification of Chief Financial Officer Pursuant to Section 302
- 13 Certification of the CEO and CFO Pursuant to Section 906
Exhibit 10.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-131387, No. 333-130534 and No. 333-111132), and on Form S-8 (No. 333-131274) of Teva Pharmaceutical Industries Limited of our report dated March 17, 2006 relating to the financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which are included in Teva Pharmaceutical Industries Limited Annual Report on Form 20-F for the year ended December 31, 2005. We also consent to the incorporation by reference of our report dated March 17, 2006 relating to the financial statement schedule, which appears in this Form 20-F.
Tel-Aviv, Israel March 17, 2006 | Kesselman & Kesselman Certified Public Accountants (Isr.) A member of PricewaterhouseCoopers International Limited |